Physiologically active compounds interacting with serotonin (5-hydroxytryptamine) receptors
作者： Ol'ga N Zefirova , Nikolai S Zefirov
DOI: 10.1070/RC2001V070N04ABEH000654
关键词: Stereochemistry 、 5-hydroxytryptamine receptors 、 Chemistry 、 Receptor 、 Serotonin
摘要: The data on the structures of organic compounds active with respect to serotonin (5-hydroxytryptamine) receptors are systematised. Various aspects their design considered. bibliography includes 296 references.
harvard.edu
rsc.org
sci-hub.se 参考文章(286)
C. Gerald, N. Adham, H.T. Kao, M.A. Olsen, T.M. Laz, L.E. Schechter, J.A. Bard, P.J. Vaysse, P.R. Hartig, T.A. Branchek, The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. The EMBO Journal. ,vol. 14, pp. 2806- 2815 ,(1995) , 10.1002/J.1460-2075.1995.TB07280.X
Yumi Sugimoto, Jun Yamada, Tomoko Yoshikawa, Kazuyoshi Horisaka, Effects of the 5-HT2C/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose levels of rats. European Journal of Pharmacology. ,vol. 307, pp. 75- 80 ,(1996) , 10.1016/0014-2999(96)00189-6
Frank D. King, Medicinal chemistry : principles and practice Royal Society of Chemistry. ,(1994)
Ariel Y. Deutch, Bita Moghaddam, Robert B. Innis, John H. Krystal, George K. Aghajanian, Benjamin S. Bunney, Dennis S. Charney, Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia. Schizophrenia Research. ,vol. 4, pp. 121- 156 ,(1991) , 10.1016/0920-9964(91)90030-U
E Zifa, G Fillion, 5-Hydroxytryptamine receptors. Pharmacological Reviews. ,vol. 44, pp. 401- 458 ,(1992)
Jon W. Lomasney, Howard S. Blaxall, Marc G. Caron, Robert J. Lefkowitz, David B. Bylund, Laurie J. Iversen, Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Molecular Pharmacology. ,vol. 42, pp. 1- 5 ,(1992)
A Schotte, W Gommeren, P Vanhoenacker, P Van Gompel, J E Leysen, A S Lesage, I Van de Weyer, G Haegeman, L Heylen, R Wouters, W H Luyten, Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan. Molecular Pharmacology. ,vol. 50, pp. 1567- 1580 ,(1996)
G M Abbate, T R Nieduzak, C J Schmidt, V L Taylor, 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa. Journal of Pharmacology and Experimental Therapeutics. ,vol. 256, pp. 230- 235 ,(1991)
E Sanders-Bush, P J Conn, Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors. Journal of Pharmacology and Experimental Therapeutics. ,vol. 242, pp. 552- 557 ,(1987)
C J Parli, M L Cohen, R W Fuller, 5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067). Journal of Pharmacology and Experimental Therapeutics. ,vol. 251, pp. 1006- 1011 ,(1989)